ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.

NSC Compound Enrichment Correlation
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0282295482823984 0.15630155
NSC 740 Methotrexate 0.0282295482823984 0.54654954
NSC 748712 Null 0.0282295482823984 0.28971106
NSC 756053 Null 0.0282295482823984 -0.15772513
NSC 119875 Cisplatin 0.0282295482823988 0.44320052
NSC 149967 Null 0.0282295482823988 0.19638626
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0282295482823988 0.38439295
NSC 24189 Null 0.0282295482823988 0.20535551
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0282295482823988 0.48585215
NSC 313985 Gold(1+), bis(trimethylphosphine)-, chloride 0.0282295482823988 0.11799817
Total:67  Current:44    [First] [Prev] [Next] [Last]